The Rheumatologist
COVID-19 NewsACR Convergence
You are here: Home / Articles / B Cell-Directed Therapy May Delay RA Development in High-Risk Patients

B Cell-Directed Therapy May Delay RA Development in High-Risk Patients

• By

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »